{"id":"W2051878959","doi":"10.3816/cbc.2010.n.023","title":"Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Eisai Canada","keywords":"Eribulin; Medicine; Metastatic breast cancer; Capecitabine; Internal medicine; Oncology; Anthracycline; Breast cancer; Taxane; Clinical endpoint; Cancer; Randomized controlled trial; Colorectal cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001040857,0.0004282916,0.002179357,0.0001788267,0.0000467729,0.00001385836,0.0001769693,0.0002176952,0.009347836],"category_scores_gemma":[0.0003092555,0.0002604661,0.0003277002,0.0005771935,0.000461049,0.000124398,0.00005893279,0.0007635176,0.00001774821],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001923659,"about_ca_system_score_gemma":0.001445109,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001695641,"about_ca_topic_score_gemma":0.00352984,"domain_scores_codex":[0.9959332,0.0003797781,0.002025954,0.0007104056,0.0004288311,0.0005218551],"domain_scores_gemma":[0.9964524,0.0008479437,0.0009391176,0.0004089835,0.0008821611,0.0004694239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1789815,0.01277089,0.385195,0.0002200713,0.001841321,0.0001701548,0.0002010465,0.00001827652,0.001251069,0.00001288709,0.003921921,0.4154159],"study_design_scores_gemma":[0.1373637,0.004472576,0.8500146,0.00092367,0.002862725,0.00009279251,0.00003274328,0.0002885812,0.0005649915,0.00002595151,0.002930962,0.0004266448],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895259,0.0005237635,0.00001299723,0.003014237,0.001494932,0.001987993,0.003312182,0.00004575557,0.00008224429],"genre_scores_gemma":[0.9960813,0.001069618,0.00022534,0.0009861498,0.000450281,0.0004682659,0.0001817201,0.00005872648,0.0004785804],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4648196,"threshold_uncertainty_score":0.9999847,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08561982642156016,"score_gpt":0.4677892660465072,"score_spread":0.382169439624947,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}